Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
budesonide (rhinocort) (1 trial)
mesalamine (rowasa) (1 trial)
Crohn Disease (Phase 3)
Trials (1 total)
Trial APIs (2 total)